GLP-1 receptor agonists also suppress glucagon release, a hormone that raises blood glucose levels, thereby helping to maintain more stable blood sugar throughout the day
Discover custom peptide manufacturing and high-purity peptide compounds available through our shop
LN has done paid lecturing and commercially sponsored research for Eli Lily, Merck, Novo Nordisk, Boehringer Ingelheim, Astra Zeneca, Sanofi Aventis, Bristol-Myers Squibb and Pfizer, and is an advisory board member for Novo Nordisk and Astra Zeneca
See her amazing before and after photos above!
However, the demographic might be expanded in Phase 2 to include a broader patient population and assess the drug's efficacy and safety across a wider spectrum of the patient population typically affected by obesity and T2DM